Literature DB >> 24917040

The vascular steal phenomenon is an incomplete contributor to negative cerebrovascular reactivity in patients with symptomatic intracranial stenosis.

Daniel F Arteaga1, Megan K Strother1, Carlos C Faraco1, Lori C Jordan2, Travis R Ladner1, Lindsey M Dethrage1, Robert J Singer3, J Mocco4, Paul F Clemmons5, Michael J Ayad6, Manus J Donahue7.   

Abstract

'Vascular steal' has been proposed as a compensatory mechanism in hemodynamically compromised ischemic parenchyma. Here, independent measures of cerebral blood flow (CBF) and blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI) responses to a vascular stimulus in patients with ischemic cerebrovascular disease are recorded. Symptomatic intracranial stenosis patients (n=40) underwent a multimodal 3.0T MRI protocol including structural (T1-weighted and T2-weighted fluid-attenuated inversion recovery) and hemodynamic (BOLD and CBF-weighted arterial spin labeling) functional MRI during room air and hypercarbic gas administration. CBF changes in regions demonstrating negative BOLD reactivity were recorded, as well as clinical correlates including symptomatic hemisphere by infarct and lateralizing symptoms. Fifteen out of forty participants exhibited negative BOLD reactivity. Of these, a positive relationship was found between BOLD and CBF reactivity in unaffected (stenosis degree<50%) cortex. In negative BOLD cerebrovascular reactivity regions, three patients exhibited significant (P<0.01) reductions in CBF consistent with vascular steal; six exhibited increases in CBF; and the remaining exhibited no statistical change in CBF. Secondary findings were that negative BOLD reactivity correlated with symptomatic hemisphere by lateralizing clinical symptoms and prior infarcts(s). These data support the conclusion that negative hypercarbia-induced BOLD responses, frequently assigned to vascular steal, are heterogeneous in origin with possible contributions from autoregulation and/or metabolism.

Entities:  

Mesh:

Year:  2014        PMID: 24917040      PMCID: PMC4158662          DOI: 10.1038/jcbfm.2014.106

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla.

Authors:  Hanzhang Lu; Chekesha Clingman; Xavier Golay; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2004-09       Impact factor: 4.668

2.  Theoretical and experimental investigation of the VASO contrast mechanism.

Authors:  Manus J Donahue; Hanzhang Lu; Craig K Jones; Richard A E Edden; James J Pekar; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

3.  Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

Authors:  C Heyn; J Poublanc; A Crawley; D Mandell; J S Han; M Tymianski; K terBrugge; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

4.  Dynamics of blood flow and oxygenation changes during brain activation: the balloon model.

Authors:  R B Buxton; E C Wong; L R Frank
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

5.  Bolus arrival time and cerebral blood flow responses to hypercarbia.

Authors:  Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

6.  Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery.

Authors:  O B Paulson
Journal:  Neurology       Date:  1970-01       Impact factor: 9.910

7.  The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study.

Authors:  Esben Thade Petersen; Kim Mouridsen; Xavier Golay
Journal:  Neuroimage       Date:  2009-08-04       Impact factor: 6.556

8.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

Authors:  Colin P Derdeyn; Tom O Videen; Kent D Yundt; Susanne M Fritsch; David A Carpenter; Robert L Grubb; William J Powers
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

9.  Vascular space occupancy (VASO) cerebral blood volume-weighted MRI identifies hemodynamic impairment in patients with carotid artery disease.

Authors:  Manus J Donahue; Peter Jan van Laar; Peter C M van Zijl; Robert D Stevens; Jeroen Hendrikse
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

10.  BOLD specificity and dynamics evaluated in humans at 7 T: comparing gradient-echo and spin-echo hemodynamic responses.

Authors:  Jeroen C W Siero; Nick F Ramsey; Hans Hoogduin; Dennis W J Klomp; Peter R Luijten; Natalia Petridou
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

View more
  10 in total

1.  Cerebral blood flow territory instability in patients with atherosclerotic intracranial stenosis.

Authors:  Daniel F Arteaga; Megan K Strother; Carlos C Faraco; L Taylor Davis; Allison O Scott; Manus J Donahue
Journal:  J Magn Reson Imaging       Date:  2019-04-02       Impact factor: 4.813

2.  Improved White Matter Cerebrovascular Reactivity after Revascularization in Patients with Steno-Occlusive Disease.

Authors:  L McKetton; L Venkatraghavan; C Rosen; D M Mandell; K Sam; O Sobczyk; J Poublanc; E Gray; A Crawley; J Duffin; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-20       Impact factor: 3.825

3.  The cumulative influence of hyperoxia and hypercapnia on blood oxygenation and R*₂.

Authors:  Carlos C Faraco; Megan K Strother; Jeroen C W Siero; Daniel F Arteaga; Allison O Scott; Lori C Jordan; Manus J Donahue
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-15       Impact factor: 6.200

4.  Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.

Authors:  Jeroen C W Siero; Nolan S Hartkamp; Manus J Donahue; Anita A Harteveld; Annette Compter; Esben T Petersen; Jeroen Hendrikse
Journal:  Neuroimage       Date:  2014-09-26       Impact factor: 6.556

5.  The effects of perturbed cerebral blood flow and cerebrovascular reactivity on structural MRI and behavioral readouts in mild traumatic brain injury.

Authors:  Justin A Long; Lora T Watts; Wei Li; Qiang Shen; Eric R Muir; Shiliang Huang; Robert C Boggs; Abhinav Suri; Timothy Q Duong
Journal:  J Cereb Blood Flow Metab       Date:  2015-06-24       Impact factor: 6.200

6.  Searching for a truly "iso-metabolic" gas challenge in physiological MRI.

Authors:  Shin-Lei Peng; Harshan Ravi; Min Sheng; Binu P Thomas; Hanzhang Lu
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

7.  Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.

Authors:  Travis R Ladner; Manus J Donahue; Daniel F Arteaga; Carlos C Faraco; Brent A Roach; L Taylor Davis; Lori C Jordan; Michael T Froehler; Megan K Strother
Journal:  J Neurosurg       Date:  2016-03-11       Impact factor: 5.115

Review 8.  Acid-base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone.

Authors:  Ebbe Boedtkjer
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-06       Impact factor: 6.200

9.  A Prospective, Longitudinal Magnetic Resonance Imaging Evaluation of Cerebrovascular Reactivity and Infarct Development in Patients With Intracranial Stenosis.

Authors:  Meher R Juttukonda; Larry T Davis; Sarah K Lants; Spencer L Waddle; Chelsea A Lee; Niral J Patel; Lori C Jordan; Manus J Donahue
Journal:  J Magn Reson Imaging       Date:  2021-03-24       Impact factor: 5.119

10.  Impact of abnormal cerebrovascular reactivity on BOLD fMRI: a preliminary investigation of moyamoya disease.

Authors:  Erin L Mazerolle; Yuhan Ma; David Sinclair; G Bruce Pike
Journal:  Clin Physiol Funct Imaging       Date:  2016-08-30       Impact factor: 2.273

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.